The 60th Annual Scientific Meeting of the European Society for Clinical Investigation (ESCI 2026) will take place at NOVA Medical School, from 3 to 5 June, under the theme “Research in Action: Building Healthier Futures”. The scientific programme will feature symposia across seven major topics, including Mitochondria: physiology and pathology, Cardiovascular and renal, Endocrinology, Metabolism & Liver, Neuroscience, Rheumatology, Women’s Health, and Clinical and Molecular Oncology.

Alongside the main programme, the meeting will also include:

• Pre-meeting Course: “From Prediction to Clinical Practice: Tools and Impact of Cardiovascular Risk Modeling”

• Workshop: “From Fundamental Discovery to Clinical Impact”

UCIBIO researchers will play an active role in the meeting, particularly within the Clinical and Molecular Oncology sessions.

• From the Glycoimmunology Research Lab, Paula Videira is co-organiser of this topic, chairing Session 1: “Tumor Immunology and Cancer Microenvironment”, and participating as an invited speaker in Session 2: “Novel therapeutic targets in clinical oncology”, where she will present the talk “Targeting Carbohydrates to Drive Innovation in Cell-Based Therapies”.

• Also from the same lab, Zélia Silva will be an invited speaker in Session 1: “Tumor Immunology and Cancer Microenvironment”, presenting the talk “Controlling CAR-T Exhaustion by Targeting Immune Checkpoint Inhibitors: Validation of an in Silico Approach”.

​​​​​​​

• From the Human Genetics and Cancer Therapeutics research lab, Alexandra R Fernandes will be an invited speaker in Session 3: “Precision Medicine and Translational Oncology”, presenting the talk “Fast and sensitive KRAS mutation detection: from solid to liquid biopsies and patient-derived organoids”.

Full programme details are available here